Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO)
"The Bowser Report's (and its readers') choice is truly gratifying," saidCEO Michael I. Ruxin, M.D. "It is a rewarding recognition of our rapid growthto 634 sites domestically and internationally as a leading supplier ofinformation management systems to U.S. and international blood centers andhospital transfusion centers that include such clients as Mayo Clinic,Memorial Sloan-Kettering Cancer Center, Stanford University Medical School,New York Presbyterian Hospital, Los Angeles' Cedars-Sinai Health System, andPittsburgh's Institute for Transfusion Medicine."
Advertisement
The Bowser Report is a monthly ten-page newsletter that recommends stockstrading at $3.00 a share or less on the NYSE, NASDAQ, AMEX and OTCBB. It isconsidered one of the investment community's top ten news letters. Only one"Company of the Month" is highlighted in each issue. The publication is nowin its 30th year. Recently a European version of The Bowser Report waslaunched. Max Bowser, founder, has authored three widely read books. Thethird edition of "Making Dollars with Pennies," will be published later thisyear.
About Global Med Technologies, Inc.
Global Med Technologies(R), Inc. is an international e-Health medicalinformation technology company providing information management softwareproducts and services to the healthcare industry. Its WyndgateTechnologies(R) division is a leading supplier of information managementsystems to U.S. and international blood centers and hospital transfusioncenters. Each year, Wyndgate's products and services manage more than eightmillion blood components, representing over 27% of the U.S. blood supply.Wyndgate's products are being used in Canada and sub-Saharan Africa, and arebeing implemented in the Caribbean. Together, the Donor Doc(TM) interactivedonor health history questionnaire, SafeTrace(R) donor management system, andthe SafeTrace Tx(R) advanced transfusion management system, recently patented,provide Vein-to-Vein(R) tracking from donor collection to patient transfusion.
For more information about Global Med's products and services, please call800-WYNDGATE or visit www.globalmedtech.com, peoplemed.com, andwww.wyndgate.com.
This news release may include statements that constitute forward-lookingstatements, usually containing the words "believe," "estimate," "project,""expects" or similar expressions. These statements are made pursuant to thesafe harbor provisions of the Private Securities Litigation Reform Act of1995. Forward-looking statements inherently involve risks and uncertaintiesthat could cause actual results to differ materially from the forward-lookingstatements. By making these forward-looking statements, the Companyundertakes no obligation to update these statements for revisions or changesafter the date of this news release.
SOURCE Global Med Technologies(R), Inc.
